(19)
(11) EP 3 407 910 A1

(12)

(43) Date of publication:
05.12.2018 Bulletin 2018/49

(21) Application number: 17702827.1

(22) Date of filing: 27.01.2017
(51) International Patent Classification (IPC): 
A61K 39/12(2006.01)
C12N 15/86(2006.01)
C07K 14/005(2006.01)
(86) International application number:
PCT/EP2017/051807
(87) International publication number:
WO 2017/129765 (03.08.2017 Gazette 2017/31)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 29.01.2016 EP 16153394
24.02.2016 EP 16157055
19.08.2016 EP 16185012

(71) Applicant: Bavarian Nordic A/S
3490 Kvistgaard (DK)

(72) Inventors:
  • STEIGERWALD, Robin
    80469 Munich (DE)
  • KALLA, Markus
    82377 Penzberg (DE)

(74) Representative: Hustert, Elisabeth 
Bavarian Nordic GmbH Fraunhoferstraße 13
82152 Martinsried
82152 Martinsried (DE)

   


(54) RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) EQUINE ENCEPHALITIS VIRUS VACCINE